Imiglucerase
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171974This classification denotes an enzyme replacement preparation with the molecular formula C2532H3843N671O711S16, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q6U6J48BWY, more generally known as imiglucerase. European Medicines Agency schedules imiglucerase in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08148MIG. The term IMIGLUCERASE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, no. 3, 1995, list 35. IMIGLUCERASE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule Imiglucerase under HS 35079090 and SITC 51691. SMILES:. As of Q4 2014, IMIGLUCERASE remains the US FDA Preferred Term for this commodity. . Imiglucerase bears US NLM identifiers UMLS ID C0291139 and NCI Concept Code C65896.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.